Fig. 5

Binding poses of bioavailable, low-toxicity CADA analogs (JGL023, JGL024, JGL032, JGL047) against the Sec61 protein channel, displayed in both ribbon and molecular surface representations. (A) JGL023 (B) JGL024 (C) JGL032 (D) JGL047.
Binding poses of bioavailable, low-toxicity CADA analogs (JGL023, JGL024, JGL032, JGL047) against the Sec61 protein channel, displayed in both ribbon and molecular surface representations. (A) JGL023 (B) JGL024 (C) JGL032 (D) JGL047.